Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 37 (1) , 1-6
- https://doi.org/10.1016/s0169-5002(01)00492-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Positron Emission Tomography in the Staging of Small-Cell Lung CancerChest, 2001
- Staging by Positron Emission Tomography Predicts Survival in Patients With Non-small Cell Lung CancerChest, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Management of Small Cell Lung CancerChest, 1999
- Staging Non-Small Cell Lung Cancer with Whole-Body PETRadiology, 1999
- Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.Journal of Clinical Oncology, 1998
- Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: Initial evaluationNuclear Medicine and Biology, 1996
- Mediastinal staging of non-small-cell lung cancer with positron emission tomography.American Journal of Respiratory and Critical Care Medicine, 1995